• The hurdles and obstacles that hydrogen manufacturing still must contend with provide companies like FuelPositive with the ability to help facilitate the zero-emission goal by providing technology to produce and utilize green ammonia affordably
• The use of green ammonia not only helps facilitate the upcoming goal of The Hydrogen Economy but it also provides a more cost-efficient and stable option
• The global green ammonia market was valued at $9.52 million in 2019 and is expected to grow at a CAGR of 53.9% over the 2020 to 2027 forecast period

The consensus at the recent UN COP26 Climate Change Conference in November 2021 was to attain carbon neutrality by 2050. Despite the number of hurdles and obstacles ahead, it was agreed that the stability of the world hangs in the balance of executing this goal. In the past, alternative renewable energy sources have been offered as a solution to the current state of the environment. The problem with alternatives like wind or solar energy is that the medium needed to keep them going is not always available. The “green” solution that has surfaced from the Climate Change Conference is what is being referred to as green hydrogen (https://ibn.fm/5uP7o). Traditional methods of producing hydrogen rely on fossil fuels, creating what has been labeled as “grey hydrogen.” This method of producing grey hydrogen results in extensive pollution in the form of greenhouse gases. However, when fossil fuels are traded for renewable resources, hydrogen can be created without producing carbon emissions. Regarding the future of green hydrogen, Columbia University’s energy policy expert Anne-Sophie Corbeau stated “Any forecast at this stage is highly uncertain, but it’s fair to say that there is a trend showing lower fossil fuel demand and higher hydrogen demand.” Canadian-based clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recognizes the potential that hydrogen has as a fuel source but also sees the potential setbacks that may surface as a result. The Hydrogen Economy, albeit the goal, still has challenges to overcome before it is a truly viable solution to replace fossil fuels and create the carbon-neutral outcome desired. Some of these challenges hydrogen production faces include:

• Requiring energy-intensive, highly polluting production
• Producing a highly-volatile end product
• Needing storage conditions that are kept under extremely high pressure and cryogenic temperatures
• Escaping at room temperature and making structures brittle
• Having a virtually non-existent distribution infrastructure
• Having severe transportation concerns attached

FuelPositive’s proprietary green ammonia production system, on the other hand, provides the solution to these hydrogen problems and more. Green ammonia needs less energy to produce than other methods of NH3 production, but with no carbon emissions. FuelPositive’s green ammonia stores 65% more hydrogen than the highly compressed hydrogen products. Given hydrogen’s current obstacles, the use of green ammonia can circumvent them – providing lower cost from start to finish, easier storage, easier transportation, and the existing ammonia infrastructure can be used. FuelPositive’s green ammonia comes with multiple advantages, such as:

• Eliminates the fertilizer-related carbon emissions in agriculture
• Replaces fossil fuels used for transportation in large engines (like farm equipment, trucks and ships)
• Provides an affordable, convenient, and sustainable supply of hydrogen for fuel cells
• Offers long-term storage of excess electricity for energy grids
• Provides electricity to northern/remote communities
• Facilitates the shift to The Hydrogen Economy
• Produces significant carbon credits as a result of emission reduction
• Reduces the need for massive, highly polluting ammonia production factories and inefficient supply chains

The benefits of green ammonia are becoming widely recognized, and the global market is expanding as a result. According to a MarketWatch research report, the global green ammonia sector was valued at $9.52 million in 2019 and is expected to grow at a CAGR of 53.9% over the 2020 to 2027 forecast period (https://ibn.fm/5jcFK). This is likely to increase as the world moves forward with the elimination of traditional fossil fuels, which are proven bad for the environment, and implements changes to facilitate the goal of carbon-neutrality by 2050. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Ketamine Wellness Centers (“KWC”) has partnered with the Veterans Administration (“VA”) Community Care Networks in Illinois and Minnesota
• KWC will provide veterans with ketamine treatments for depression, chronic pain and PTSD at no out-of-pocket cost at these locations
• Meet Delic was held on November 6 and 7 and became the world’s largest psychedelic wellness event

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, has announced its subsidiary, Ketamine Wellness Centers LLC (“KWC”), has entered two new partnerships with the Veteran Administration (“VA”) Community Care Networks of Illinois and Minnesota. KWC, which boasts the nation’s largest chain of psychedelic wellness clinics, will offer ketamine treatments to veterans at no out-of-pocket cost at their locations in Naperville, IL and Burnsville, MN. The program will cover patients who have suffered from post-traumatic stress disorders, major depression, and chronic pain, and who have exhausted all traditional medical treatments. Vancouver-based Delic recently sought to expand its presence within the psychedelic wellness space, entering into a merger agreement with KWC in mid-September. Under the terms of the deal, Delic agreed to acquire KWC’s chain of 10 ketamine infusion clinics, operating across Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas and Washington and merge them with Delic’s existing two ketamine clinics operating under the Ketamine Infusions Centers (“KIC”) (https://ibn.fm/gpJoC). Delic now expects to open 15 additional clinics across the country over the coming 18 months, in a bid to further its goal of expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions and cementing its position as the leader and largest provider of psychedelic wellness in the U.S. Regarding the partnership between KWC and the VA, Delic co-founder Matt Stang said: “This partnership between KWC and the VA Community Care Network is a true game changer when it comes to the health and wellness of our veterans. They face steep challenges when returning home, especially related to their mental and physical health, including PTSD, depression, and pain. Now they can seek the treatment they need without worrying about whether they can afford it. These brave men and women have sacrificed so much to protect this country and we are honored to support them.” Meet Delic was held on November 6 and 7 and sold out, becoming the world’s largest psychedelic wellness and business conference with over 2,500 attendees from around the world, more than 60 speakers, and 20 hours of programming. Headliners included former NBA star Lamar Odom, who was joined by director Zappy Zapolin and shared his story of addiction and recovery through ketamine treatments, and Duncan Trussell, the actor and comedian who hosted a live taping of his popular Family Hour podcast with author Aubrey Marcus, Vince Kadlubek, founder of Meow Wolf, and actor Johnny Pemberton. “We’re incredibly humbled and unbelievably inspired by the number of people who came out to Meet Delic and joined the conversation on the power of psychedelics to heal and to remove the stigmas surrounding them,” said Jackee Stang, co-founder of Delic. “The world and our minds have evolved, and so should our medicines. We’re already looking forward to 2022 and how we can continue to show the world the latest in proven health and wellness benefits of psychedelics.” Meet Delic 2022 will be held on November 4 and 5 in Las Vegas and tickets are on sale now. For more information, visit the company’s website at www.DelicCorp.com and the Meet Delic conference website at www.MeetDelic.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• Cardiovascular diseases are the leading cause of death worldwide and arterial stiffness serves as a significant marker of related conditions, including hypertension (high blood pressure)
• The company’s studies earlier this year indicated the potential of DehydraTECH to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation
• Arterial stiffness is a noted indicator of diseases such as heart, kidney and pancreas organ ailments that increase mortality with age, therefore the ability to reduce arterial stiffness may have implications for improving human wellness and longevity
• HYPER-H21-2 results evidence DehydraTECH-CBD reduces arterial stiffness

Lexaria Bioscience (NASDAQ: LEXX), an innovator in how drugs are utilized by the human body, is reporting newly found benefits from cannabidiol (“CBD”) enhanced by Lexaria’s patented DehydraTECH(TM) technology. The company’s Dec. 8 news release notes that DehydraTECH-formulated CBD was found to reduce arterial stiffness in mild-to-moderate hypertension (high blood pressure) patients volunteering in Lexaria’s HYPER-H21-2 human clinical study (https://ibn.fm/MJ0Xc). The company believes the findings may have a potential impact on efforts to treat not only high blood pressure, but other cardiovascular diseases and other ailments in which blood vessel stiffness is believed to play a significant role. “Reducing arterial stiffness in Lexaria’s recent hypertension study after only a single day of dosing with our DehydraTECH-CBD is a major discovery,” Lexaria President John Docherty stated in the news release. “We know that increased arterial stiffness is correlated with many serious and life-threatening diseases affecting people worldwide, and we are optimistic that our latest findings could have future widespread implications for promotion of improved human health and wellness.” Lexaria’s examination of DehydraTECH-CBD’s effects on arterial stiffness follows its initial findings between July (https://ibn.fm/rUgQV) and September (https://ibn.fm/0tFtD) that hypertensive volunteers using the company’s processed CBD achieved a marked drop in blood pressure relative to generic CBD controls used as a placebo. DehydraTECH is an enabling technological solution that helps drug substances bypass the digestion-liver filtering cycle that may reduce their effectiveness. DehydraTECH’s platform works with the body to rapidly process drugs into the blood stream before potentially being filtered out by the liver’s enzyme-generating factory. Additional testing by Canada’s premier federally funded research organization, the National Research Council demonstrated DehydraTECH processing and formulation technology does not create a covalently bonded new molecular entity (“NME”) and that each drug tested remained stable and did not undergo change in chemical structure.  These findings are strongly supportive of accelerated regulatory filings such as the 505(b)(2) pathway permitted by the Food and Drug Administration and other international regulators, for more rapid market authorizations of prospective DehydraTECH-enabled, repurposed drugs (https://ibn.fm/YfxNf). Lexaria will follow the HYPER-H21-2 study with two new hypertension studies, HYPER-H21-3 and HYPER-H21-4, a new six-week investigation in which multiple doses of DehydraTECH-CBD are expected to indicate further benefits for treating hypertension and arterial stiffness. Arterial stiffness naturally increases with age and is associated with increased mortality from diseases such as diabetes mellitus and kidney disorders, as well as the cardiovascular diseases that are the leading cause of death worldwide (https://ibn.fm/zizu8). Dr. Vernon V S Bonarjee, the head of the cardiology department at Norway’s Stavanger University Hospital, has noted that measuring arterial stiffness may serve as a predictive indicator for determining treatment for cardiovascular disease, even among otherwise asymptomatic individuals, demonstrating the condition’s significance (https://ibn.fm/siA0F). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Eat Well’s leadership team has founded, built, and sold a previous multi-hundred-million-dollar plant-based food company
• The company’s vertical integration offers an opportunity to invest in the value chain from seed-to-market, rather than a single brand or segment
• Eat Well’s portfolio of companies are uniquely positioned at the epicenter of grower relationships, supply chains and innovation
• The company’s majority owned subsidiary, Amara Organic Foods, has been named the number-one new release on Amazon for its toddler line
• Eat Well’s portfolio revenue is projected to accelerate from $60 million in 2021 to $100 million in 2022

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022. Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company. The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products. Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada. Portfolio On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein. Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today. Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch. Market Outlook According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research. Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply. Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition. The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue. Management Team Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales. Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing. Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management. Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses. Strategic Advisory Board HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth. Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• DigiMax partners with BearClaw Esports to provide mutually beneficial collaboration
• Bitget partnership gives Cryptohawk users great opportunity to increase the efficiency and security of their trades
• DIGI join forces with prominent leader in the crypto industry in Asia

Powerful partnerships are key to a company’s success, and over the past six months, DigiMax Global (CSE: DIGI) (OTC: DBKSF) has built a portfolio of powerful partnerships, all designed to support the company’s strategic global efforts to unlock the potential of disruptive technologies by providing advanced financial, predictive and cryptocurrency solutions across various verticals. Last month, DigiMax announced a partnership with BearClaw Esports (https://ibn.fm/0h3UQ). The collaboration will give BearClaw’s community of streaming gamers and Esports followers access to DIGI’s CryptoHawk artificial intelligence (“AI”) products and information. “Esports gamers are well known for their affiliation with cryptocurrencies, with many gamers also using their computer hardware to mine and trade a wide variety of cryptocurrencies,” DIGI noted when announcing the partnership. “At $180 billion and growing by 20% in 2020, the video game category is now bigger than sports and movie revenue combined. . . . Gamers and crypto traders have a great deal in common, and most do both already and often on the same machines as more and more gamers are converting their gaming machines into miners in their spare time. Prior to its BearClaw announcement, DigiMax partnered with Singapore-based Bitget, a crypto exchange (https://ibn.fm/4WKBV). The agreement calls for DigiMax and Bitget to collaborate on mutually beneficial business arrangements, including allowing Btiget users to learn about DigiMax’s CryptoHawk and giving CryptoHawk direct access to Bitgets’ platform. “By partnering with Bitget, Cryptohawk users will have a great opportunity to increase the efficiency and security of their trades,” said DigiMax CEO Chris Carl. “But in the near future, they will have access to automated trading from Cryptohawk signals. We look forward to partnering with Bitget to deliver ever-increasing value to both our users now and in the future.” Earlier this year, DigiMax inked its first collaboration agreement to expand CryptoHawk services into Hong Kong and surrounding areas (https://ibn.fm/rRIt2). Based on the partnership agreement, DigiMax will collaborate with Tony Tong in Hong Kong and other Asian regions where he has substantial influence. According to the company, Tong is cochair and cofounder of the Hong Kong Blockchain Association, a council member of International Digital Asset Exchange Association and president of GlobalSTOx.io & APX.HK. The collaboration agreement between DigiMax and Tong includes the issuance of 200,000 common shares of DigiMax and an award of additional shares as he assists DigiMax in successfully completing partnering deals with exchanges or directly increasing the number of CryptoHawk subscribers in Asia. “We are excited to be able to join forces with Tony Tong who we respect as a prominent leader in the crypto industry in Asia,” said Carl. “Tony has been a leader and an innovator in every facet of the blockchain and crypto currency space, and we are certain that CryptoHawk can deliver a whole new level of value and power to anyone interested in trading or owning crypto currencies in their portfolio. DIGI’s powerful partnership portfolio is only one indication of the company’s commitment to produce and leverage predictive indicators across various industries and verticals as well as offer financial, business, and human capital AI predictive solutions to businesses, institutions and consumers. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

• MCOA just posted its highest quarterly revenue yet in Q3 2021, attributed to the cDistro acquisition, which was completed towards the end of Q2 2021
• MCOA looks forward to having another record-breaking quarter in Q4, 2021, primarily attributed to additional benefits of the cDistro acquisition, along with strategic partnerships with key players within the legal cannabis and industrial hemp sectors
• The company continues to forge these partnerships to diversify its product and services line and provide consistent value to its shareholders

Marijuana Company of America (OTC: MCOA) released financial results for the three months ended September 30, 2021 (“Q3 2021”), posting a 731% year-on-year increase from the same period in Q3 2020. Total revenue stood at $442,178 up from $53,195, with gross profit up from $16,025 in Q3 2020 to $63,687, representing a 297% growth over that period (https://ibn.fm/otRva). MCOA has attributed this impressive growth to its new acquisition of cDistro, an enterprise that distributes CBD brans, smoke, and vape shop-related products to specialty retailers, wholesalers, c-stores, and consumers within the North American market (https://ibn.fm/qD0DC). The acquisition, completed towards the end of Q2 2021, was a tremendous milestone for MCOA. But, more importantly, it positioned the company to take advantage of immediate revenue granted by the opportunity to carve out a significant market share in the specialty distribution space. With this acquisition, and the steps taken so far regarding expanding the company’s market reach and product line, MCOA is confident that it will have another record-breaking quarter in Q4 2021. “We are confident that the steps we are taking will enable us to maintain a growing strong position as we drive growth across the entire business and maximize value for our shareholders over the long term. Our expectation is that we should have another record-breaking quarter in Q4 2021, since we will report a full quarter of revenue from our newly acquired cultivation facility in Salinas, California,” noted Jesus Quintero, the Chief Executive Officer (“CEO”) of MCOA. In addition to acquisitions, MCOA has also tapped into strategic industry partnerships to push its growth. So far, it has operations in North America and Latin America, primarily through partnerships with enterprises such as Cannabis Global Inc. (OTC: CBGL), Eco Innovation Group Inc. (OTC: ECOX) and Natural Plant Extract. CBGL currently markets and produces innovative cannabis storage, transport, and tracking solutions and is also the company behind the Hemp You Can Feel(TM) brand. ECOX, on the other hand, has cutting-edge extraction technology that utilizes a proprietary formulation to extract bioactive compounds from cannabidiol, which is then combined with plant-based materials to create a fluid and cost-effective outcome. Natural Plant Extract operates a licensed cannabis manufacturing and distribution business in Lynwood, California. MCOA remains committed to expanding into new regions around the world. Its goal is to utilize its resources and its strategic partners’ success to continue growing its product and services line. Ultimately, this will provide consistent value to shareholders while also sealing its position as the leader in the legal cannabis and industrial hemp sectors. For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• Point-of-care pharmacy services developer Avricore Health is celebrating the successes of its pilot program to roll out testing resources at select pharmacies across Canada this year
• Avricore’s trademarked HealthTab platform, working with corporate partners, has provided a popular alternative to doctor clinics for getting test results related to pre-diabetes and heart disease conditions, for example
• The HealthTab setup, in conjunction with multinational medical devices and health care company Abbott Laboratories, is also able to screen for viruses such as SARS-CoV-2, RSV, influenza A and B, and strep
• Market analysts predict POC testing revenues will continue to grow through 2025 at a CAGR of 11.4 percent from 2020’s $29.5 billion levels

Health care solutions innovator Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is rolling into the new year with building momentum, celebrating its accomplishments amid global pandemic conditions and surveying the expected growth market for point-of-care (“POC”) testing revenue. “We’ve had our best year yet, despite many external factors that created headwinds, and we’re extremely excited to head into 2022,” Avricore Health CEO Hector Bremner told investors during the company’s year-end call Dec. 15. “Given that we are well capitalized and have executed several key agreements already, we’re well positioned for growth.” Avricore has turned its focus to point-of-care testing as a means of helping patients access information necessary for managing their health without having to deal with busy doctor’s offices. With the help of trained pharmacists, patients can get lab-quality data through a platform ultimately designed to improve their health outcomes and lower overall healthcare costs (https://ibn.fm/kgWma). Avricore’s trademarked HealthTab platform is a communications network that relays the data derived from POC testing kiosks to the interested parties in a patient privacy-respecting manner. Avricore has established partnerships with kiosk design, pharmacy and lab testing partners for its pilot program rollout in Canada and is continuing to build on the positive outcomes of those partnerships. Pharmacists already accustomed to dispensing medications and providing vaccinations have expressed an interest in adding lab testing and results oversight, particularly in Canada where it could mitigate lost revenues following the adverse impacts of the Pan-Canadian Select Molecule Price Initiative for Generic Drugs in 2018 (https://ibn.fm/1NWxb). Analysts at Markets and Markets are forecasting a growing market for POC testing, predicting last year’s overall revenues of $29.5 billion will grow to $50.6 billion by 2025, defining a CAGR of 11.4 percent (https://ibn.fm/KQLZh). Markets and Markets’ report anticipates glucose monitoring for diabetes will be the largest growing sector of the market, and Avricore has made services for monitoring pre-diabetes and cardiovascular conditions a foundational part of its pilot program. Avricore’s non-exclusive distribution agreement in Canada to work with multinational medical devices and health care company Abbott Laboratories on the pilot program’s testing setup is using Abbott’s handheld blood chemistry analyzer, i-STAT Alinity, to help chronic kidney disease patients monitor their creatinine levels, for example, as a means of determining if medication dosing needs to be adjusted because of the amount of renal-excreted drugs for diabetes or cardiovascular disease being filtered through their kidneys. “Understanding renal function in patients at risk from or already living with chronic disease is critical,” Bremner stated last month (https://ibn.fm/KzFzu). “With i-STAT Alinity and its associated test for creatinine, healthcare professionals can obtain results in approximately two minutes to detect elevated levels of creatinine that are associated with abnormal renal function.” The Abbott agreement also allows for the technology to detect viruses such as COVID’s SARS-CoV-2, RSV, influenza A and B, and strep (https://ibn.fm/cNTNc) to be utilized in a pharmacy setting, making it easier for patients to streamline decisions related to short-term sicknesses. For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Flora Growth’s subsidiary, Vessel Brand, recently introduced new products for dry herb consumption and anticipates releasing additional products in 2022
• FLGC acquired Vessel in a transaction that closed in November
• Founded in 2018, Vessel is an industry leader in the cannabis consumer technology and accessories space
• Flora Growth also announced a 2022 revenue guidance of $35-45 million
• CEO Luis Merchan held a webinar on December 14 in which he highlighted the company’s 2021 operational performance, commented on the revenue guidance, and fielded questions

Flora Growth (NASDAQ: FLGC), an internationally focused company committed to delivering the most compelling customer experiences in the world through its collection of plant-based wellness and lifestyle brands, is building an ecosystem of products that will support market-leading innovation within categories that matter most to consumers exploring plant-based consumer goods. In fulfilling this objective as well as its operational tenet ‘lead by design’, Flora Growth recently announced its wholly owned subsidiary, Vessel Brand, had introduced a robust portfolio of new products for dry herb consumption (https://ibn.fm/PBhYJ). The products include Helix, a patent-pending one-hitter made of pure brass for the cleanest inhalation and featuring a spiralized interior that doubles the length of the smoke path and filters as residue builds up; Eclipse Kit, an all-in-one dry herb smoking kit that includes a Drift case, a one-hitter, an inverted Carbon lighter, and a Basin stash jar; Ash, an exquisite and artful ashtray made with concrete and genuine walnut; and Grinder, a four-piece premium grinder made with precision-engineered aluminum and magnetic closures for easy use. Vessel anticipates releasing other new dry herb accessories in 2022, including a small, lightweight grinder with wood inlay and textured grip. “At Vessel, we work tirelessly to set new industry standards and look forward to continuing to deliver on that brand promise within the dry herb market,” said Vessel CEO and Founder James Choe. “These new products are just the beginning of what Vessel has in store for consumers across the globe.” Acquired by Flora Growth in a transaction that closed in November, Vessel is an industry leader in cannabis consumer technology and accessories. The company strives to develop and offer products that elevate and personalize the consumption experience while delivering the best performance. Since its establishment in 2018, Vessel has witnessed rapid revenue growth by leveraging a go-to-market strategy for direct-to-consumer sales in the United States and global cannabis market. Its trailing 12-months revenue stood at $6.6 million, representing a 90% year-over-year increase (https://ibn.fm/G8TAm). Vessel finds continued success by bringing to market innovative products and experiences that raise users’ expectations – the recently announced products, as well as those slated for launch in 2022, attest to this. Meanwhile, revenues from Vessel as well as Flora’s other operating divisions, including wholesale cannabis revenues from its Cosechemos farm in Colombia, contributed to a 2022 revenue guidance of $35-45 million issued in a December 6 press release (https://ibn.fm/lQmeF). Flora subsequently held a webinar on December 14, in which CEO Luis Merchan updated shareholders and listeners on the company’s operational performance for 2021 to date, provided additional comments on the revenue guidance, and fielded questions. As an internationally focused cannabis brand builder, Flora Growth has expanded its product offerings, assets, and brand portfolio through investments and acquisitions. So far, the brands and assets affiliated with the company can be found within the cannabis and hemp, food and beverage, skincare and cosmetics, lifestyle and apparel, ancillary and technology (under which Vessel falls), and nutraceuticals and wellness spaces. Along with the design-led approach, which combines product design, user experience (“UX”), packaging, and social and environmental thoughtfulness to promote customer experience and engagement, Flora Growth focuses on building an experienced workforce as well as a community of customers. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• PlantX has launched its first branded mobile app, PlantX Shop
• The app will complement and expand the company’s existing e-commerce capabilities and enhance customers’ plant-based experience
• PlantX hopes to also capitalize on the mobile app space, which accounts for about 70% of all e-commerce sales
• This launch shows PlantX’s commitment to enhancing customer engagement and satisfaction as the leader in the plant-based space

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) has, since its inception, worked towards serving as the digital face of the plant-based community. This is evidenced by its PlantX platform, a one-stop shop for everything plant-based. The company is taking things a notch higher with the launch of PlantX Shop, its new PlantX-branded mobile application that will be available both on iOS and Android for customers in the United States and Canada. PlantX hopes this application will complement and expand its existing e-commerce capabilities while also offering an opportunity to upgrade customers’ plant-based experience (https://ibn.fm/WZIQU). This new app packs various features geared towards enhancing the PlantX shopping process. For instance, users will save their shipping information and passwords, allowing faster checkout times. In addition, they will also use an integrated QR code scanning feature for easy and seamless self-checkout in all XMarket retail stores, which would significantly increase the speed and efficiency of the checkout process. PlantX Shop users will access more than 5,000 plant-based grocery items, beauty products, indoor plants, and beverages. They will also have access to its XFood program, a plant-based meal delivery service currently available throughout Canada. Users will also enjoy an increasing variety of new, creative, and interesting plant-based tips and recipes that will diversify and grow their plant-based cooking experience. For PlantX, bringing this app to consumers is an opportunity to distinguish itself in an industry that is growing more competitive by the day. PlantX is committed to positioning itself as a leader in the plant-based space, and the launch of this app has taken it closer to achieving that objective. The app has taken time and resources to develop, and with this launch, PlantX hopes that it will capitalize on the app space that currently accounts for about 70% of all e-commerce sales globally. Moreover, the company looks to collect data through this app’s usage to help inform its efforts to tailor products and services to individual customers’ preferences. This, it projects, will enhance its marketing strategy, increase sales and even grow its customer retention. “The new PlantX app offers a truly exciting advantage in interacting with our community in more efficient and dynamic ways,” noted Lorne Rapkin, the Chief Executive Officer (“CEO”) of PlantX. PlantX plans to add more features, such as the QR code scanning functionality, to its app in the coming year. It hopes that incremental improvements to the application will further enhance the customer experience while inching the company closer to dominating the plant-based market. It projects that this will also increase its e-commerce sales by offering customers a more convenient shopping option. “We are always looking to develop new strategies that can help us upgrade our customers’ plant-based experience. PlantX Shop is an extremely exciting tool that allows us to go above and beyond to improve our customers’ satisfaction,” noted Sean Dollinger, the Founder of PlantX. This app’s launch has shown Plant’s commitment to enhancing customer engagement and satisfaction by facilitating a faster, more straightforward, and more interactive shopping experience. Going forward, shareholders and customers can expect further innovations from the company as its stamps its position as the digital face of the plant-based community. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• DEAL emerging as clear leader based on the consistent increases in key metrics of success
• Company reported that total player wagering for November 2021 increased approximately 12% compared to October 2021
• CEO notes that reception from our partners, clients has been unparalleled

In the burgeoning iGaming space, key indicators measure a company’s success. One of those indicators is player wagering activity, and Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (Frankfurt: 7CR), a propriety SaaS technology company delivering mobile live dealer technology to online gaming operators globally, is emerging as a clear leader based on the consistent increases in player wagering activity the company is reporting. Most recently, Playgon announced that its total player wagering for November 2021 increased approximately 12% compared to October 2021. Furthermore, monthly active player numbers are up 28%, and bet spots have increased over 22%, compared to the previous month (https://ibn.fm/x0xY7). And those aren’t the only numbers worth noting; the company also added three new operators to its platform, bringing the total number of operators using Playgon tech to 26, with eight more waiting in the wings at various stages of integration of testing. “We continue to garner strong interest and onboard operators rapidly as the demand for our product continues to grow at a healthy pace,” said Playgon Games CEO Darcy Krogh. “Player activity and wagering are important metrics of the success of our mobile live-dealer product, and we are delighted with the growth we are experiencing. For the second month in a row, we are delivering record increases in player wagering, which is a direct function of the growing number of users leveraging our platform as we offer our games through some of the largest gaming operators globally.” The increase in numbers has been a bit of a pattern for the gaming company. In October, the company announced that it had surpassed $24.2 million in player betting turnover in the first half of the month, up from $1.6 million for the entire month of September, an increase of over 1,500% (https://ibn.fm/EHXpT). At the time, Krogh noted that daily player betting turnover was tracking at approximately $1.6 million per day, up from about $53,500 per day for the month of September. “We are extremely excited about our month-over-month growth,” he said. “We knew our proprietary technology was innovative; however, the reception we have received from our partners and clients has been unparalleled. This is noticeable from the player wagering activity, which has increased to 305,000 bets for the half month of October compared to 132,000 bets for the entire month of September. We are witnessing at least 100% growth across all of our key indicators. “As we look ahead to the new year, we anticipate continued growth in client acquisition and player activity with a material number of new operators coming online and ultimately strong revenue growth,” Krogh concluded. “We are confident in our strategy and look forward to continued growth and success.” Playgon games is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes live-dealer table games, eTable games, and daily fantasy sports. Seamless integration at the operator level allows customer access without sharing or compromising any sensitive customer data. As a true B2B digital content provider, Playgon’s products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups, and big database companies. For more information, visit the company’s website at www.Playgon.com. NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF